Literature DB >> 10702803

DNA methylator and mismatch repair phenotypes are not mutually exclusive in colorectal cancer cell lines.

M M Pao1, G Liang, Y C Tsai, Z Xiong, P W Laird, P A Jones.   

Abstract

A potential link between DNA repair and de novo methylation of exogenous sequences in colorectal cancer cell lines suggested that cells deficient in mismatch repair (MMR-) had an increased ability to silence the introduced virus promoter by DNA methylation due to the presence of a methylator phenotype (MET+) (Lengauer et al., 1997a). We explored this relationship in more detail and found that although there was a clear difference in the abilities of MMR+ cells to express the viral promoter compared to their MMR- counterparts, this difference was not consistently explained by levels of methylation in the viral promoter. Furthermore, we were unable to distinguish differences between the levels of methylation of six endogenous known CpG islands or 100 random DNA fragments containing CCGG sites within the cells. No consistent differences between the abilities of the cells to methylate the CpG island in exon 2 of the p16 gene were observed after transient demethylation by 5-aza-2'-deoxycytidine nor in the levels of expression of three human methyltransferase enzymes. Our results do not therefore support the existence of mutually exclusive DNA methylation (MET) and DNA repair (MMR) phenotypes. Oncogene (2000) 19, 943 - 952.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10702803     DOI: 10.1038/sj.onc.1203414

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  5 in total

1.  Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.

Authors:  F Magdinier; A P Wolffe
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

Review 2.  Methylation matters.

Authors:  J F Costello; C Plass
Journal:  J Med Genet       Date:  2001-05       Impact factor: 6.318

3.  DNA methyltransferase deficiency modifies cancer susceptibility in mice lacking DNA mismatch repair.

Authors:  Binh N Trinh; Tiffany I Long; Andrea E Nickel; Darryl Shibata; Peter W Laird
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

4.  Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells.

Authors:  Jonathan C Cheng; Daniel J Weisenberger; Felicidad A Gonzales; Gangning Liang; Guo-Liang Xu; Ye-Guang Hu; Victor E Marquez; Peter A Jones
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

5.  Acquired resistance to 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) in glioblastoma cells.

Authors:  Nathalie Gaspar; Swee Y Sharp; Simon Pacey; Chris Jones; Michael Walton; Gilles Vassal; Suzanne Eccles; Andrew Pearson; Paul Workman
Journal:  Cancer Res       Date:  2009-02-24       Impact factor: 12.701

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.